Cancer Drug Development with Drs. A. Adjei and W. Cance

Sunday, January 29, 2012

Alex A. Adjei, MD, PhD, Senior Vice President of Clinical Research and Chair of the Department of Medicine, and William Cance, MD, formerly of RPCI, discuss trends in cancer pharmacotherapy at RPCI and worldwide. They also address the concerning drug shortages that have affected cancer patients nationwide.